Literature DB >> 16900272

Utility assessment to measure the impact of dry eye disease.

Patricia Buchholz1, Carolyn S Steeds, Lee S Stern, Daniel P Wiederkehr, John J Doyle, Laura M Katz, Francisco C Figueiredo.   

Abstract

Utility assessment is a formal method for quantifying and understanding the relative impact of a given health state or disease on patients. In this article, methodology of utility assessment is explained and illustrated, and results of an original study are reported. The study was conducted to determine utility values (patient preferences) associated with dry eye disease and compare them to other disease utilities, as well as to compare patient and physician assessments of disease. Forty-four patients in the United Kingdom with moderate to severe dry eye were surveyed via interactive utility assessment software. Utility values were measured by the Time Trade-Off (TTO) and Standard Gamble (SG) methods and adjusted to scores from 1.0=perfect health to 0.0=death. Patients reported utilities for: self-reported current dry eye status, self-reported current comorbidities, various dry eye severities, and binocular and monocular painful blindness. Patient's dry eye severity was independently classified by patient and physician assessments. Correlation analyses (Pearson) were performed between patients' current dry eye utilities and the physician-assessed severity. Agreement between self-reported and physician-reported patient severity was analyzed (Kappa). Patients reported higher utilities for their current dry eye condition than for monocular and binocular blindness (SG:0.84>0.60>0.51; TTO:0.67>0.43>0.38). Using TTO, the mean score for asymptomatic dry eye (0.68) was similar to that for "some physical and role limitations with occasional pain" and severe dry eye requiring surgery scored (0.56) similarly to hospital dialysis (0.56-0.59) and severe angina (0.5). Utilities described for scenarios of dry eye severity levels were slightly higher for patients self-reported as mild-to-moderate versus those self-reported as severe. For current dry eye condition, mean utilities for these groups were 0.72 for self-reported mild-to-moderate and 0.61 for self-reported severe. Utilities for dry eye were in the range of conditions accepted as lowering health utilities. Severe dry eye utilities were similar to those reported for dialysis and severe angina, highlighting the impact of dry eye disease on patients.

Entities:  

Mesh:

Year:  2006        PMID: 16900272     DOI: 10.1016/s1542-0124(12)70043-5

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  45 in total

Review 1.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

2.  Five things to know about...dry eye disease.

Authors:  Rahul A Sharma; Rookaya Mather
Journal:  CMAJ       Date:  2014-05-12       Impact factor: 8.262

Review 3.  Effects of Aging in Dry Eye.

Authors:  Cintia S de Paiva
Journal:  Int Ophthalmol Clin       Date:  2017

4.  Ocular Manifestations and Burden Related to Sjögren Syndrome: Results of a Patient Survey.

Authors:  Ian J Saldanha; Vatinee Y Bunya; Sara S McCoy; Matthew Makara; Alan N Baer; Esen K Akpek
Journal:  Am J Ophthalmol       Date:  2020-06-20       Impact factor: 5.258

5.  Tolerability of Topical Tocilizumab Eyedrops in Dogs: A Pilot Study.

Authors:  Vatinee Y Bunya; Simone Iwabe; Ilaria Macchi; Mina Massaro-Giordano; Maxwell Pistilli; Gustavo D Aguirre
Journal:  J Ocul Pharmacol Ther       Date:  2017-06-26       Impact factor: 2.671

6.  Association between clinical diagnostic tests and health-related quality of life surveys in patients with dry eye syndrome.

Authors:  Yoshinobu Mizuno; Masakazu Yamada; Yozo Miyake
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

Review 7.  A review of quality of life measures in dry eye questionnaires.

Authors:  Joseph R Grubbs; Sue Tolleson-Rinehart; Kyle Huynh; Richard M Davis
Journal:  Cornea       Date:  2014-02       Impact factor: 2.651

8.  Dry Eye Disease: Impact on Quality of Life and Vision.

Authors:  Miki Uchino; Debra A Schaumberg
Journal:  Curr Ophthalmol Rep       Date:  2013-06

Review 9.  The eye: a window of opportunity in rheumatoid arthritis?

Authors:  Louis Tong; Julian Thumboo; York Kiat Tan; Tien-Yin Wong; Salvatore Albani
Journal:  Nat Rev Rheumatol       Date:  2014-06-10       Impact factor: 20.543

10.  Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population.

Authors:  Surasak Saokaew; Wichittra Tassaneeyakul; Ratree Maenthaisong; Nathorn Chaiyakunapruk
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.